RÉSUMÉ
Glutamate is involved in fundamental functions, including neuronal plasticity and memory. Astrocytes are integral elements involved in synaptic function, and the GLT-1 transporter possesses a critical role in glutamate uptake. Here, we study the role of GLT-1, specifically located in astrocytes, in the consolidation, expression, reconsolidation and persistence of spatial object recognition memory in rats. Administration of dihydrokainic acid (DHK), a selective GLT-1 inhibitor, into the dorsal hippocampus around a weak training which only induces short-term memory, promotes long-term memory formation. This promotion is prevented by hippocampal administration of protein-synthesis translation inhibitor, blockade of Activity-regulated cytoskeleton-associated protein (Arc) translation or Brain-Derived Neurotrophic Factor (BDNF) action, which are plasticity related proteins necessary for memory consolidation. However, DHK around a strong training, which induces long-term memory, does not affect memory consolidation. Administration of DHK before the test session impairs the expression of long-term memory, and this effect is dependent of Arc translation. Furthermore, DHK impairs reconsolidation if applied before a reactivation session, and this effect is independent of Arc translation. These findings reveal specific consequences on spatial memory stages developed under hippocampal GLT-1 blockade, shedding light on the intricate molecular mechanisms, governed in part for the action of glia.
Sujet(s)
Astrocytes , Facteur neurotrophique dérivé du cerveau , Protéines du cytosquelette , Acide glutamique , Hippocampe , Mémoire spatiale , Animaux , Hippocampe/effets des médicaments et des substances chimiques , Hippocampe/métabolisme , Hippocampe/physiologie , Astrocytes/effets des médicaments et des substances chimiques , Astrocytes/métabolisme , Mémoire spatiale/effets des médicaments et des substances chimiques , Facteur neurotrophique dérivé du cerveau/métabolisme , Mâle , Rats , Protéines du cytosquelette/métabolisme , Protéines du cytosquelette/génétique , Acide glutamique/métabolisme , Protéines de tissu nerveux/métabolisme , Protéines de tissu nerveux/antagonistes et inhibiteurs , Protéines de tissu nerveux/génétique , Transporteur-2 d'acides aminés excitateurs/métabolisme , Transporteur-2 d'acides aminés excitateurs/antagonistes et inhibiteurs , Rat Wistar , Acide kaïnique/pharmacologie , Acide kaïnique/analogues et dérivés , Consolidation de la mémoire/effets des médicaments et des substances chimiquesRÉSUMÉ
Consumption of saturated fat-enriched diets during adolescence has been closely associated with the reduction of hippocampal synaptic plasticity and the impairment of cognitive function. Nevertheless, the effect of long-term intake of these foods has not yet been studied. In the present study, we have investigated the effect of a treatment, lasting for 40 weeks, with a diet enriched in saturated fat (SOLF) on i) spatial learning and memory, ii) hippocampal synaptic transmission and plasticity, and iii) hippocampal gene expression levels in aged male and female mice. Our findings reveal that SOLF has a detrimental impact on spatial memory and synaptic plasticity mechanisms, such as long-term potentiation (LTP), and downregulates Gria1 expression specifically in males. In females, SOLF downregulates the gene expression of Gria1/2/3 and Grin1/2A/2B glutamate receptor subunits as well as some proinflammatory interleukins. These findings highlight the importance of considering sex-specific factors when assessing the long-term effects of high-fat diets on cognition and brain plasticity.
Sujet(s)
Alimentation riche en graisse , Hippocampe , Caractères sexuels , Animaux , Mâle , Femelle , Hippocampe/effets des médicaments et des substances chimiques , Hippocampe/métabolisme , Alimentation riche en graisse/effets indésirables , Souris , Souris de lignée C57BL , Plasticité neuronale/effets des médicaments et des substances chimiques , Plasticité neuronale/physiologie , Apprentissage spatial/effets des médicaments et des substances chimiques , Apprentissage spatial/physiologie , Récepteur de l'AMPA/métabolisme , Mémoire spatiale/effets des médicaments et des substances chimiques , Mémoire spatiale/physiologie , Mémoire/effets des médicaments et des substances chimiques , Mémoire/physiologie , Potentialisation à long terme/effets des médicaments et des substances chimiques , Potentialisation à long terme/physiologie , Récepteurs du N-méthyl-D-aspartate/métabolisme , Transmission synaptique/effets des médicaments et des substances chimiques , Transmission synaptique/physiologie , Matières grasses alimentaires/pharmacologieRÉSUMÉ
Hepatic encephalopathy (HE) is a neuropsychiatric syndrome that can occur in people with acute or chronic liver disease. Here, we investigated the effects of menthol, a natural monoterpene, on HE induced by thioacetamide (TA) in male Wistar rats. The rats received 200 mg/kg of TA twice a week for four weeks and were administered 10 mg/kg of menthol intraperitoneally daily for the same period. The results showed that menthol treatment reduced oxidative stress and inflammation in the livers and hippocampi of the rats that received TA. It also lowered the levels of ammonium and liver enzymes AST, ALT, ALP, and GGT in the serum of these animals and prevented liver histopathological damage. In addition, the expression and activity of acetylcholinesterase in the hippocampus of HE model rats were decreased by menthol. Likewise, this monoterpene reduced the expression of TLR4, MyD88, and NF-κB in the hippocampus while increasing the expression of BDNF and α7-nACh receptor. Menthol also reduced neuronal death in the hippocampal cornu ammonis-1 and dentate gyrus regions and reduced astrocyte swelling, which led to improved learning and spatial memory in rats with HE. In conclusion, the study suggests that menthol may have strong protective effects on the liver and brain, making it a potential treatment for HE and neurodegenerative diseases.
Sujet(s)
Facteur neurotrophique dérivé du cerveau , Encéphalopathie hépatique , Hippocampe , Menthol , Stress oxydatif , Rat Wistar , Mémoire spatiale , Thioacétamide , Récepteur de type Toll-4 , Animaux , Mâle , Stress oxydatif/effets des médicaments et des substances chimiques , Encéphalopathie hépatique/traitement médicamenteux , Encéphalopathie hépatique/métabolisme , Encéphalopathie hépatique/induit chimiquement , Encéphalopathie hépatique/prévention et contrôle , Facteur neurotrophique dérivé du cerveau/métabolisme , Rats , Menthol/pharmacologie , Mémoire spatiale/effets des médicaments et des substances chimiques , Hippocampe/effets des médicaments et des substances chimiques , Hippocampe/métabolisme , Hippocampe/anatomopathologie , Récepteur de type Toll-4/métabolisme , Foie/effets des médicaments et des substances chimiques , Foie/métabolisme , Foie/anatomopathologie , Inflammation/traitement médicamenteux , Inflammation/métabolisme , Facteur de transcription NF-kappa B/métabolisme , Facteur de différenciation myéloïde-88/métabolisme , Neuroprotecteurs/pharmacologie , Neuroprotecteurs/usage thérapeutique , Acetylcholinesterase/métabolismeRÉSUMÉ
This study explores the under-researched domain of long-term stimulant treatment in children and adolescents diagnosed with attention deficit hyperactivity disorder (ADHD). The necessity for extended treatment duration, often accompanied by safety concerns and side effects leading to treatment discontinuation, underscores the significance of this investigation. Concurrently, comparative studies have revealed adverse impacts on vulnerable regions within the hippocampal formation, accompanied by behavioral perturbations. We employed computerized tests and virtual reality to assess spatial memory, pattern separation, and object recognition memory in a cohort of children diagnosed with ADHD receiving stimulant treatment. We compared their performance to a group of neurotypical peers. Our findings indicate that the ADHD group exhibited a lower performance in spatial memory, pattern separation, and object recognition memory than ND group. Intriguingly, a positive relationship emerged between the duration of stimulant treatment and performance in these variables. Notably, this improvement was not immediate to MPH treatment but becomes significant after 24 months of treatment. In contrast to previous comparative investigations, our study did not reveal a detrimental impact on spatial navigation, object recognition memory, or pattern separation, despite the known interplay of these cognitive processes with the hippocampal formation. These results shed new light on the nuanced effects of stimulant treatment in ADHD, underscoring the need for a more comprehensive understanding of long-term treatment outcomes.
Sujet(s)
Trouble déficitaire de l'attention avec hyperactivité , Stimulants du système nerveux central , Méthylphénidate , , Mémoire spatiale , Humains , Trouble déficitaire de l'attention avec hyperactivité/traitement médicamenteux , Mémoire spatiale/effets des médicaments et des substances chimiques , Mémoire spatiale/physiologie , Mâle , Stimulants du système nerveux central/pharmacologie , Stimulants du système nerveux central/administration et posologie , Stimulants du système nerveux central/effets indésirables , Femelle , Enfant , Adolescent , /effets des médicaments et des substances chimiques , Méthylphénidate/pharmacologie , Méthylphénidate/effets indésirables , Méthylphénidate/administration et posologie , Hippocampe/effets des médicaments et des substances chimiques , Tests neuropsychologiquesRÉSUMÉ
Previously, we found that dCA1 A1-like polarization of astrocytes contributes a lot to the spatial memory deficit in methamphetamine abstinence mice. However, the underlying mechanism remains unclear, resulting in a lack of promising therapeutic targets. Here, we found that methamphetamine abstinence mice exhibited an increased M1-like microglia and A1-like astrocytes, together with elevated levels of interleukin 1α and tumor necrosis factor α in dCA1. In vitro, the M1-like BV2 microglia cell medium, containing high levels of Interleukin 1α and tumor necrosis factor α, elevated A1-like polarization of astrocytes, which weakened their capacity for glutamate clearance. Locally suppressing dCA1 M1-like microglia activation with minocycline administration attenuated A1-like polarization of astrocytes, ameliorated dCA1 neurotoxicity, and, most importantly, rescued spatial memory in methamphetamine abstinence mice. The effective time window of minocycline treatment on spatial memory is the methamphetamine exposure period, rather than the long-term methamphetamine abstinence.
Sujet(s)
Astrocytes , Troubles de la mémoire , Métamfétamine , Microglie , Minocycline , Mémoire spatiale , Animaux , Métamfétamine/toxicité , Microglie/effets des médicaments et des substances chimiques , Microglie/métabolisme , Souris , Troubles de la mémoire/induit chimiquement , Astrocytes/métabolisme , Astrocytes/effets des médicaments et des substances chimiques , Astrocytes/anatomopathologie , Mémoire spatiale/physiologie , Mémoire spatiale/effets des médicaments et des substances chimiques , Mâle , Minocycline/pharmacologie , Souris de lignée C57BL , Syndrome de sevrage/métabolisme , Syndrome de sevrage/anatomopathologie , Stimulants du système nerveux central/toxicitéRÉSUMÉ
Both hypertension and aging are known to increase the vulnerability of the brain to neurovascular damage, resulting in cognitive impairment. The present study investigated the efficacy of the antihypertensive drug losartan on age- and hypertension-associated cognitive decline and the possible mechanism underlying its effect in spontaneously hypertensive rats (SHRs). Losartan was administered (10 mg/kg, i.p. for 19 days) to 3- and 14-month-old SHRs. Age-matched Wistar rats were used as controls. Working memory, short-term object recognition, and spatial memory were assessed using the Y-maze, object recognition test (ORT) and radial arm maze (RAM) test. The expression of markers associated with aging, oxidative stress, and memory-related signaling was assessed in the frontal cortex (FC) and hippocampus. Motor activity measured over 24 h was not different between groups. Middle-aged vehicle-treated SHRs showed poorer performance in spontaneous alternation behavior (SAB) and activity in the first Y-maze test than their younger counterparts, suggesting age-related reduced "decision making" and reactivity in a novel environment. Losartan improved the age- and hypertension-induced decline in short-term recognition and spatial memory measured in the ORT and the second Y-maze test, particularly in the middle-aged rats, but was ineffective in the young adult rats. Changes in memory and age-related markers such as cAMP response element-binding protein (CREB) and amyloid-ß1-42 (Aß1-42) and increased oxidative stress were observed in the hippocampus but not in the FC between young adult and middle-aged vehicle-treated SHRs. Losartan increased CREB expression while reducing Aß1-42 levels and concomitant oxidative stress in middle-aged SHRs compared with vehicle-treated SHRs. In conclusion, our study highlights the complex interplay between hypertension, aging, and cognitive impairment. It suggests that there is a critical time window for therapeutic intervention with angiotensin II type 1 receptor blockers.
Sujet(s)
Vieillissement , Antagonistes du récepteur de type 1 de l'angiotensine-II , Dysfonctionnement cognitif , Hypertension artérielle , Losartan , Apprentissage du labyrinthe , Stress oxydatif , Rats de lignée SHR , Animaux , Losartan/pharmacologie , Losartan/usage thérapeutique , Rats , Dysfonctionnement cognitif/traitement médicamenteux , Dysfonctionnement cognitif/étiologie , Dysfonctionnement cognitif/métabolisme , Mâle , Vieillissement/effets des médicaments et des substances chimiques , Stress oxydatif/effets des médicaments et des substances chimiques , Hypertension artérielle/traitement médicamenteux , Hypertension artérielle/métabolisme , Apprentissage du labyrinthe/effets des médicaments et des substances chimiques , Antagonistes du récepteur de type 1 de l'angiotensine-II/pharmacologie , Antagonistes du récepteur de type 1 de l'angiotensine-II/usage thérapeutique , Rat Wistar , Hippocampe/métabolisme , Hippocampe/effets des médicaments et des substances chimiques , Mémoire spatiale/effets des médicaments et des substances chimiques , Protéine de liaison à l'élément de réponse à l'AMP cyclique/métabolisme , Antihypertenseurs/pharmacologie , Antihypertenseurs/usage thérapeutiqueRÉSUMÉ
Estrogens have inconsistent effects on learning and memory in both the clinical and preclinical literature. Preclinical literature has the advantage of investigating an array of potentially important factors contributing to the varied effects of estrogens on learning and memory, with stringently controlled studies. This study set out to identify specific factors in the animal literature that influence the effects of estrogens on cognition, for possible translation back to clinical practice. The literature was screened and studies meeting strict inclusion criteria were included in the analysis. Eligible studies included female ovariectomized rodents with an adequate vehicle for the estrogen treatment, with an outcome of spatial learning and memory in the Morris water maze. Training days of the Morris water maze were used to assess acquisition of spatial learning, and the probe trial was used to evaluate spatial memory recall. Continuous outcomes were pooled using a random effects inverse variance method and reported as standardized mean differences with 95 % confidence intervals. Subgroup analyses were developed a priori to assess important factors. The overall analysis favoured treatment for the later stages of training and for the probe trial. Factors including the type of estrogen, route, schedule of administration, age of animals, timing relative to ovariectomy, and duration of treatment were all found to be important. The subgroup analyses showed that chronic treatment with 17ß-estradiol, either cyclically or continuously, to young animals improved spatial recall. These results, observed in animals, can inform and guide further clinical research on hormone replacement therapy for cognitive benefits.
Sujet(s)
Oestrogènes , Apprentissage spatial , Mémoire spatiale , Animaux , Femelle , Oestradiol/pharmacologie , Oestradiol/administration et posologie , Oestrogènes/pharmacologie , Oestrogènes/administration et posologie , Apprentissage du labyrinthe/effets des médicaments et des substances chimiques , Apprentissage du labyrinthe/physiologie , Mémoire/effets des médicaments et des substances chimiques , Mémoire/physiologie , Ovariectomie , Rodentia/physiologie , Apprentissage spatial/effets des médicaments et des substances chimiques , Apprentissage spatial/physiologie , Mémoire spatiale/effets des médicaments et des substances chimiques , Mémoire spatiale/physiologieRÉSUMÉ
Major Depressive Disorder affects 8.4 % of the U.S. population, particularly women during perimenopause. This study implemented a chronic corticosterone manipulation (CORT, a major rodent stress hormone) using middle-aged, ovariectomized female rats to investigate depressive-like behavior, anxiety-like symptoms, and cognitive ability. CORT (400 µg/ml, in drinking water) was administered for four weeks before behavioral testing began and continued throughout all behavioral assessments. Compared to vehicle-treated rats, CORT significantly intensified depressive-like behaviors: CORT decreased sucrose preference, enhanced immobility on the forced swim test, and decreased sociability on a choice task between a novel conspecific female rat and an inanimate object. Moreover, CORT enhanced anxiety-like behavior on a marble bury task by reducing time investigating tabasco-topped marbles. No effects were observed on novelty suppressed feeding or the elevated plus maze. For spatial working memory using an 8-arm radial arm maze, CORT did not alter acquisition but disrupted performance during retention. CORT enhanced the errors committed during the highest working memory load following a delay and during the last trial requiring the most items to remember; this cognitive metric positively correlated with a composite depressive-like score to reveal that as depressive-like symptoms increased, cognitive performance worsened. This protocol allowed for the inclusion of multiple behavioral assessments without stopping the CORT treatment needed to produce a MDD phenotype and to assess a battery of behaviors. Moreover, that when middle-age was targeted, chronic CORT produced a depressive-like phenotype in ovariectomized females, who also comorbidly expressed aspects of anxiety and cognitive dysfunction.
Sujet(s)
Corticostérone , Dépression , Mémoire à court terme , Ovariectomie , Mémoire spatiale , Animaux , Femelle , Rats , Mémoire à court terme/effets des médicaments et des substances chimiques , Mémoire à court terme/physiologie , Dépression/induit chimiquement , Mémoire spatiale/effets des médicaments et des substances chimiques , Mémoire spatiale/physiologie , Apprentissage du labyrinthe/effets des médicaments et des substances chimiques , Apprentissage du labyrinthe/physiologie , Anxiété/induit chimiquement , Comportement animal/effets des médicaments et des substances chimiques , Comportement animal/physiologie , Rat Sprague-DawleyRÉSUMÉ
Alzheimer's disease (AD) is a neurological condition that is connected with a decline in a person's memory as well as their cognitive ability. One of the key topics of AD research has been the exploration of metabolic causes. We investigated the effects of treadmill exercise and intranasal insulin on learning and memory impairment and the expression of IGF1, BDNF, and GLUT4 in hypothalamus. The animals were put into 9 groups at random. In this study, we examined the impact of insulin on spatial memory in male Wistar rats and analyzed the effects of a 4-week pretreatment of moderate treadmill exercise and insulin on the mechanisms of improved hypothalamic glucose metabolism through changes in gene and protein expression of IGF1, BDNF, and GLUT4. We discovered that rat given Aß25-35 had impaired spatial learning and memory, which was accompanied by higher levels of Aß plaque burden in the hippocampus and lower levels of IGF1, BDNF, and GLUT4 mRNA and protein expression in the hypothalamus. Additionally, the administration of exercise training and intranasal insulin results in the enhancement of spatial learning and memory impairments, the reduction of plaque burden in the hippocampus, and the enhancement of the expression of IGF1, BDNF, and GLUT4 in the hypothalamus of rats that were treated with Aß25-35. Our results show that the improvement of learning and spatial memory due to the improvement of metabolism and upregulation of the IGF1, BDNF, and GLUT4 pathways can be affected by pretreatment exercise and intranasal insulin.
Sujet(s)
Maladie d'Alzheimer , Modèles animaux de maladie humaine , Transporteur de glucose de type 4 , Hypothalamus , Facteur de croissance IGF-I , Insuline , Conditionnement physique d'animal , Rat Wistar , Transduction du signal , Animaux , Maladie d'Alzheimer/métabolisme , Maladie d'Alzheimer/traitement médicamenteux , Maladie d'Alzheimer/thérapie , Facteur de croissance IGF-I/métabolisme , Mâle , Insuline/métabolisme , Rats , Hypothalamus/métabolisme , Transduction du signal/effets des médicaments et des substances chimiques , Transporteur de glucose de type 4/métabolisme , Transporteur de glucose de type 4/génétique , Peptides bêta-amyloïdes/métabolisme , Facteur neurotrophique dérivé du cerveau/métabolisme , Facteur neurotrophique dérivé du cerveau/génétique , Hippocampe/métabolisme , Hippocampe/effets des médicaments et des substances chimiques , Administration par voie nasale , Fragments peptidiques , Mémoire spatiale/effets des médicaments et des substances chimiques , Apprentissage spatial/effets des médicaments et des substances chimiquesRÉSUMÉ
BACKGROUND: The mutually beneficial coevolutionary relationships between rodents and plant seeds have been a theme of research in plant-animal relationships. Seed tannins are important secondary metabolites of plants that regulate the food-hoarding behavior of rodents; however, the underlying molecular mechanisms are not yet clear. In this study, we investigated whether and how seed tannins improve spatial memory and regulate the hoarding behavior of Tamias sibiricus by altering their gut microbiota. RESULTS: We showed that acorn tannins not only improved spatial memory but also enhanced scatter-hoarding in T. sibiricus. Changes in the composition and function of the gut microbiota in response to tannins from acorns are closely related to these improvements. Metabonomic analyses revealed the role of gut isovaleric acid and isobutyric acid as well as serum L-tryptophan in mediating the spatial memory of T. sibiricus via the gut microbiota. The hippocampal proteome provides further evidence that the microbiota-gut-brain axis regulates spatial memory and scatter-hoarding in animals. Our study is likely the first to report that plant secondary metabolites improve hippocampal function and spatial memory and ultimately modulate food-hoarding behavior via the microbiota-gut-brain axis. CONCLUSION: Our findings may have resolved the long-standing puzzle about the hidden role of plant secondary metabolites in manipulating food-hoarding behavior in rodents via the microbiota-gut-brain axis. Our study is important for better understanding the mutualistic coevolution between plants and animals. Video Abstract.
Sujet(s)
Axe cerveau-intestin , Microbiome gastro-intestinal , Hippocampe , Mémoire spatiale , Tanins , Animaux , Microbiome gastro-intestinal/effets des médicaments et des substances chimiques , Mémoire spatiale/effets des médicaments et des substances chimiques , Tanins/pharmacologie , Hippocampe/métabolisme , Axe cerveau-intestin/physiologie , Graines , Mâle , Tryptophane/métabolisme , Comportement animal/effets des médicaments et des substances chimiquesRÉSUMÉ
To contribute to research on female models of Alzheimer's disease (AD), our aim was to study the effect of intracerebroventricular (ICV) injection of streptozotocin (STZ) in female rats, and to evaluate a potential neuroprotective action of ovarian steroids against STZ. Female rats were either ovariectomized (OVX) or kept with ovaries (Sham) two weeks before ICV injections. Animals were injected with either vehicle (artificial cerebrospinal fluid, aCSF) or STZ (3 mg/kg) and separated into four experimental groups: Sham + aCSF, Sham + STZ, OVX + aCSF and OVX + STZ. Nineteen days post-injection, we assessed different behavioral aspects: burying, anxiety and exploration, object recognition memory, spatial memory, and depressive-like behavior. Immunohistochemistry and Immunoblot analyses were performed in the hippocampus to examine changes in AD-related proteins and neuronal and microglial populations. STZ affected burying and exploratory behavior depending on ovarian status, and impaired recognition but not spatial memory. STZ and ovariectomy increased depressive-like behavior. Interestingly, STZ did not alter the expression of ß-amyloid peptide or Tau phosphorylated forms. STZ affected the neuronal population from the Dentate Gyrus, where immature neurons were more vulnerable to STZ in OVX rats. Regarding microglia, STZ increased reactive cells, and the OVX + STZ group showed an increase in the total cell number. In sum, STZ partially affected female rats, compared to what was previously reported for males. Although AD is more frequent in women, reports about the effect of ICV-STZ in female rats are scarce. Our work highlights the need to deepen into the effects of STZ in the female brain and study possible sex differences.
Sujet(s)
Maladie d'Alzheimer , Ovariectomie , Streptozocine , Animaux , Femelle , Maladie d'Alzheimer/induit chimiquement , Maladie d'Alzheimer/métabolisme , Rats , Injections ventriculaires , Rat Wistar , Hippocampe/effets des médicaments et des substances chimiques , Hippocampe/métabolisme , Ovaire/effets des médicaments et des substances chimiques , Ovaire/métabolisme , Dépression/induit chimiquement , Dépression/métabolisme , Peptides bêta-amyloïdes/métabolisme , Mémoire spatiale/effets des médicaments et des substances chimiquesRÉSUMÉ
BACKGROUND: The study investigated the effect of co-administration of curcumin and donepezil on several markers of cognitive function (such as spatial memory, astrocyte activation, cholinesterase expressions) in the brain cortex and hippocampus of scopolamine-treated rats. METHOD AND RESULTS: For seven consecutive days, a pre-treatment of curcumin (50 mg/kg) and/or donepezil (2.5 mg/kg) was administered. On the seventh day, scopolamine (1 mg/kg) was administered to elicit cognitive impairment, 30 min before memory test was conducted. This was followed by evaluating changes in spatial memory, cholinesterase, and adenosine deaminase (ADA) activities, as well as nitric oxide (NO) level were determined. Additionally, RT-qPCR for glial fibrillary acidic protein (GFAP) and cholinesterase gene expressions was performed in the brain cortex and hippocampus. Also, GFAP immunohistochemistry of the brain tissues for neuronal injury were performed in the brain cortex and hippocampus. In comparison to the control group, rats given scopolamine had impaired memory, higher levels of acetylcholinesterase (AChE), butyrylcholinesterase (BChE), and ADA activities, as well as elevated markers of oxidative stress. In addition to enhanced GFAP immunoreactivity, there was also overexpression of the GFAP and BChE genes in the brain tissues. The combination of curcumin and donepezil was, however, observed to better ameliorate these impairments in comparison to the donepezil-administered rat group. CONCLUSION: Hence, this evidence provides more mechanisms to support the hypothesis that the concurrent administration of curcumin and donepezil mitigates markers of cognitive dysfunction in scopolamine-treated rat model.
Sujet(s)
Acetylcholinesterase , Astrocytes , Curcumine , Donépézil , Protéine gliofibrillaire acide , Hippocampe , Scopolamine , Mémoire spatiale , Animaux , Donépézil/pharmacologie , Curcumine/pharmacologie , Curcumine/administration et posologie , Scopolamine/pharmacologie , Astrocytes/effets des médicaments et des substances chimiques , Astrocytes/métabolisme , Rats , Mâle , Mémoire spatiale/effets des médicaments et des substances chimiques , Acetylcholinesterase/métabolisme , Acetylcholinesterase/génétique , Hippocampe/effets des médicaments et des substances chimiques , Hippocampe/métabolisme , Protéine gliofibrillaire acide/métabolisme , Protéine gliofibrillaire acide/génétique , Encéphale/effets des médicaments et des substances chimiques , Encéphale/métabolisme , Rat Wistar , Stress oxydatif/effets des médicaments et des substances chimiques , Cholinesterases/métabolisme , Adenosine deaminase/métabolisme , Adenosine deaminase/génétique , Butyrylcholine esterase/métabolisme , Butyrylcholine esterase/génétique , Monoxyde d'azote/métabolisme , Anticholinestérasiques/pharmacologie , Anticholinestérasiques/administration et posologieRÉSUMÉ
Acetaminophen (APAP) is a leading cause of acute liver failure. The effect of APAP metabolite's effects in the periphery are well characterized; however, associated consequences in the brain remain poorly understood. Animal studies on this subject are few and reveal that frequent APAP intake can trigger cerebral abnormalities that vary depending on the subject's age. Alarmingly, experimental efforts have yet to examine associated consequences in elderly hosts, who correspond to the highest risk of medication overload, impaired drug clearance, and cognitive deficits. Here, we interrogated the cerebral and peripheral pathology of elderly mice submitted to monthly episodes of APAP intoxication since a young adult age. We found that weeks after the final episode of recurrent APAP exposure, mice exhibited worsened non-spatial memory deficit whereas spatial memory performance was unaltered. Interestingly, one month after the period of APAP intoxication, these mice showed increased glial burden without associated drivers, namely, blood-brain barrier disruption, cholesterol accumulation, and elevation of inflammatory molecules in the brain and/or periphery. Our experimental study reveals how recurrent APAP exposure affects the cognitive performance and cellular events in elderly brains. These data suggest that APAP-containing pharmacological interventions may foreshadow the elevated risk of neuropsychiatric disorders that afflict elderly populations.
Sujet(s)
Acétaminophène , Astrocytes , Dysfonctionnement cognitif , Microglie , Animaux , Acétaminophène/toxicité , Acétaminophène/effets indésirables , Dysfonctionnement cognitif/induit chimiquement , Dysfonctionnement cognitif/anatomopathologie , Dysfonctionnement cognitif/métabolisme , Souris , Astrocytes/métabolisme , Astrocytes/effets des médicaments et des substances chimiques , Astrocytes/anatomopathologie , Microglie/métabolisme , Microglie/effets des médicaments et des substances chimiques , Microglie/anatomopathologie , Mâle , Encéphale/métabolisme , Encéphale/effets des médicaments et des substances chimiques , Encéphale/anatomopathologie , Souris de lignée C57BL , Barrière hémato-encéphalique/métabolisme , Barrière hémato-encéphalique/effets des médicaments et des substances chimiques , Vieillissement , Modèles animaux de maladie humaine , Mémoire spatiale/effets des médicaments et des substances chimiquesRÉSUMÉ
Clothianidin (CLO), a neonicotinoid that is widely used in forests and agricultural areas, was recently reported to cause toxicity in mammals. Although sensitivity to chemicals varies between sexes and developmental stages, studies that comprehensively evaluate both males and females are limited. Therefore, in this study we utilized murine models to compare the sex-specific differences in behavioral effects following CLO exposure at different developmental stages. We orally administered CLO to male and female mice as a single high-dose solution (80 mg/kg) during the postnatal period (2-week-old), adolescence (6-week-old), or maturity (10-week-old), and subsequently evaluated higher brain function. The behavioral battery test consisted of open field, light/dark transition, and contextual/cued fear conditioning tests conducted at three and seven months of age. After the behavioral test, the brains were dissected and prepared for immunohistochemical staining. We observed behavioral abnormalities in anxiety, spatial memory, and cued memory only in female mice. Moreover, the immunohistochemical analysis showed a reduction in astrocytes within the hippocampus of female mice with behavioral abnormalities. The behavioral abnormalities observed in female CLO-treated mice were consistent with the typical behavioral abnormalities associated with hippocampal astrocyte dysfunction. It is therefore possible that the CLO-induced behavioral abnormalities are at least in part related to a reduction in astrocyte numbers. The results of this study highlight the differences in behavioral effects following CLO exposure between sexes and developmental stages.
Sujet(s)
Comportement animal , Guanidines , Hippocampe , Néonicotinoïdes , Thiazoles , Animaux , Femelle , Néonicotinoïdes/toxicité , Guanidines/toxicité , Guanidines/administration et posologie , Mâle , Comportement animal/effets des médicaments et des substances chimiques , Thiazoles/toxicité , Thiazoles/administration et posologie , Hippocampe/effets des médicaments et des substances chimiques , Caractères sexuels , Peur/effets des médicaments et des substances chimiques , Astrocytes/effets des médicaments et des substances chimiques , Anxiété/induit chimiquement , Souris , Facteurs sexuels , Mémoire spatiale/effets des médicaments et des substances chimiques , Administration par voie orale , Insecticides/toxicitéRÉSUMÉ
BACKGROUND: Alzheimer's disease (AD) is a complex and common neurodegenerative disorder. The present study aimed to investigate the potential effects of selegiline (SEL) on various aspects of memory performance, anxiety, and oxidative stress in an AD rat model induced by intracerebroventricular injection of amyloid beta1-42 (Aß1-42). METHODS: Oral administration of SEL at a dose of 0.5 mg/kg/day was performed for 30 consecutive days. Following the 30 days, several tests, including the open-field, elevated plus-maze, novel object recognition, Morris water maze, and passive avoidance learning were conducted to assess locomotor activity, anxiety-like behavior, recognition memory, spatial memory, and passive avoidance memory, respectively. RESULTS: The results indicate that the induction of AD in rats led to recognition memory, spatial memory, and passive avoidance memory impairments, as well as increased anxiety. Additionally, the AD rats exhibited a decrease in total antioxidant capacity and an increase in total oxidant status levels, suggesting an imbalance in oxidative-antioxidant status. However, the administration of SEL improved memory performance, reduced anxiety, and modulated oxidative-antioxidant status in AD rats. CONCLUSIONS: These findings provide evidence that SEL may alleviate anxiety-like behavior and cognitive deficits induced by Aß through modulation of oxidative-antioxidant status.
Sujet(s)
Maladie d'Alzheimer , Peptides bêta-amyloïdes , Anxiété , Troubles de la mémoire , Stress oxydatif , Sélégiline , Animaux , Peptides bêta-amyloïdes/métabolisme , Anxiété/traitement médicamenteux , Anxiété/induit chimiquement , Rats , Mâle , Sélégiline/pharmacologie , Sélégiline/administration et posologie , Troubles de la mémoire/traitement médicamenteux , Troubles de la mémoire/induit chimiquement , Stress oxydatif/effets des médicaments et des substances chimiques , Maladie d'Alzheimer/traitement médicamenteux , Maladie d'Alzheimer/induit chimiquement , Modèles animaux de maladie humaine , Apprentissage par évitement/effets des médicaments et des substances chimiques , Fragments peptidiques , Mémoire spatiale/effets des médicaments et des substances chimiques , Apprentissage du labyrinthe/effets des médicaments et des substances chimiques , Rat Wistar , /effets des médicaments et des substances chimiques , Comportement animal/effets des médicaments et des substances chimiques , Neuroprotecteurs/pharmacologie , Neuroprotecteurs/administration et posologie , Antioxydants/pharmacologie , Antioxydants/administration et posologieRÉSUMÉ
Drug addiction may result in sleep problems. Importantly, sleep deprivation (SD) is known as an important risk factor for relapse to drug abuse as SD mimics the effects of psychostimulants on dopamine system of the brain. Moreover, aging may affect sleep and drug addiction. This study, therefore, set out to assess the effects of methamphetamine (METH) and REM sleep deprivation (RSD) on locomotor activity, anxiety-like behavior and spatial memory in adult and adolescent rats. Adult and adolescent male Wistar rats received a neurotoxic METH regimen; four subcutaneous injections of 6 mg/kg, at 2 h intervals. Five days later, the animals underwent a 48-h RSD episode using the multiple platforms method. They were then examined using the open field (OF), elevated plus maze (EPM) and Y-maze tasks. We found that the METH and RSD paradigms showed synergistic effects to increase locomotion and risk-taking behavior in both adult and adolescent animals, while only adolescent rats revealed RSD-induced anxiety-like behavior. Moreover, adolescent animals revealed greater sensitization for vertical activity following METH plus RSD episode. In addition, METH and RSD paradigms revealed synergistic effects to impair spatial working memory, but neither METH nor RSD alone affected performance of animals in the Y-maze task. Our findings may indicate that there are important relationships between METH and RSD to induce hyperlocomotion, risk-taking behavior and spatial memory impairment, particularly in adolescent animals. Moreover, it seems that adolescent rats may be more susceptible to anxiety-like behavior and hyperlocomotion than adults.
Sujet(s)
Anxiété , Stimulants du système nerveux central , Apprentissage du labyrinthe , Métamfétamine , Rat Wistar , Privation de sommeil , Animaux , Métamfétamine/pharmacologie , Mâle , Stimulants du système nerveux central/pharmacologie , Apprentissage du labyrinthe/effets des médicaments et des substances chimiques , Rats , Mémoire spatiale/effets des médicaments et des substances chimiques , Mémoire spatiale/physiologie , Locomotion/effets des médicaments et des substances chimiques , Locomotion/physiologie , Sommeil paradoxal/effets des médicaments et des substances chimiques , Sommeil paradoxal/physiologie , Activité motrice/effets des médicaments et des substances chimiques , Comportement animal/effets des médicaments et des substances chimiques , Vieillissement/physiologie , Vieillissement/effets des médicaments et des substances chimiquesRÉSUMÉ
Neuroinflammation has been implicated in cognitive deficits of neurological and neurodegenerative diseases. There is abundant evidence that the application of ghrelin, an orexigenic hormone regulating appetite and energy balance, abrogates neuroinflammation and rescues associated memory impairment. However, the underlying mechanism is uncertain. In this study, we find that both intraperitoneal (i.p.) and intracerebroventricular (i.c.v.) administration of lipopolysaccharide (LPS) impairs spatial memory in mice. LPS treatment causes neuroinflammation and microglial activation in the hippocampus. Ghsr1a deletion suppresses LPS-induced microglial activation and neuroinflammation, and rescued LPS-induced memory impairment. Our findings thus suggest that GHS-R1a signaling may promote microglial immunoactivation and contribute to LPS-induced neuroinflammation. GHS-R1a may be a new therapeutic target for cognitive dysfunction associated with inflammatory conditions.
Sujet(s)
Lipopolysaccharides , Troubles de la mémoire , Souris de lignée C57BL , Microglie , Récepteurs à la ghréline , Mémoire spatiale , Animaux , Mémoire spatiale/effets des médicaments et des substances chimiques , Récepteurs à la ghréline/déficit , Récepteurs à la ghréline/génétique , Récepteurs à la ghréline/métabolisme , Troubles de la mémoire/génétique , Troubles de la mémoire/induit chimiquement , Troubles de la mémoire/métabolisme , Souris , Mâle , Microglie/métabolisme , Microglie/effets des médicaments et des substances chimiques , Microglie/anatomopathologie , Hippocampe/métabolisme , Hippocampe/effets des médicaments et des substances chimiques , Hippocampe/anatomopathologie , Souris knockout , Maladies neuro-inflammatoires/métabolisme , Maladies neuro-inflammatoires/anatomopathologieRÉSUMÉ
The effects of intra-hippocampal manipulation of glycine receptors on the reconsolidation of recent and late long-term spatial memory were evaluated and assessed in the Morris water maze. The results obtained from the intra-hippocampal infusion of glycine and taurine demonstrated that taurine at a 100 nmol/side dose impaired the reconsolidation of recent and late long-term spatial memory. In comparison, at a dose of 10 nmol/side, it only affected the reconsolidation of late long-term spatial memory, reinforcing that there are differences between molecular mechanisms underlying recent and late long-term memory reconsolidation. On the other hand, glycine impaired the reconsolidation of early and late spatial memory when infused at a dose of 10 nmol/side, but not at a dose of 100 nmol/side, unless it is co-infused with an allosteric site antagonist of the NMDA receptor. Altogether these results show that glycine acting in situ in the hippocampal CA1 region exerts a pharmacological effect on U-curve, which can be explained by its concomitant action on its ionotropic receptor GlyR and on its NMDA receptor co-agonist site.
Sujet(s)
Glycine , Mémoire à long terme , Rat Wistar , Récepteur de la glycine , Mémoire spatiale , Taurine , Animaux , Récepteur de la glycine/métabolisme , Récepteur de la glycine/effets des médicaments et des substances chimiques , Mâle , Glycine/pharmacologie , Rats , Mémoire spatiale/effets des médicaments et des substances chimiques , Mémoire spatiale/physiologie , Mémoire à long terme/effets des médicaments et des substances chimiques , Mémoire à long terme/physiologie , Taurine/pharmacologie , Taurine/administration et posologie , Hippocampe/effets des médicaments et des substances chimiques , Hippocampe/métabolisme , Consolidation de la mémoire/effets des médicaments et des substances chimiques , Consolidation de la mémoire/physiologie , Récepteurs du N-méthyl-D-aspartate/antagonistes et inhibiteurs , Récepteurs du N-méthyl-D-aspartate/métabolisme , Récepteurs du N-méthyl-D-aspartate/effets des médicaments et des substances chimiques , Région CA1 de l'hippocampe/effets des médicaments et des substances chimiques , Région CA1 de l'hippocampe/métabolisme , Région CA1 de l'hippocampe/physiologie , Apprentissage du labyrinthe/effets des médicaments et des substances chimiques , Apprentissage du labyrinthe/physiologieRÉSUMÉ
BACKGROUND: Methamphetamine (METH) is a psychostimulant substance with highly addictive and neurotoxic effects, but no ideal treatment option exists to improve METH-induced neurocognitive deficits. Recently, mesenchymal stem cells (MSCs)-derived exosomes have raised many hopes for treating neurodegenerative sequela of brain disorders. This study aimed to determine the therapeutic potential of MSCs-derived exosomes on cognitive function and neurogenesis of METH-addicted rodents. METHODS: Male BALB/c mice were subjected to chronic METH addiction, followed by intravenous administration of bone marrow MSCs-derived exosomes. Then, the spatial memory and recognition memory of animals were assessed by the Barnes maze and the novel object recognition test (NORT). The neurogenesis-related factors, including NeuN and DCX, and the expression of Iba-1, a microglial activation marker, were assessed in the hippocampus by immunofluorescence staining. Also, the expression of inflammatory cytokines, including TNF-α and NF-κB, were evaluated by western blotting. RESULTS: The results showed that BMSCs-exosomes improved the time spent in the target quadrant and correct-to-wrong relative time in the Barnes maze. Also, NORT's discrimination index (DI) and recognition index (RI) were improved following exosome therapy. Additionally, exosome therapy significantly increased the expression of NeuN and DCX in the hippocampus while decreasing the expression of inflammatory cytokines, including TNF-α and NF-κB. Besides, BMSC-exosomes down-regulated the expression of Iba-1. CONCLUSION: Our findings indicate that BMSC-exosomes mitigated METH-caused cognitive dysfunction by improving neurogenesis and inhibiting neuroinflammation in the hippocampus.
Sujet(s)
Troubles liés aux amphétamines , Protéine doublecortine , Exosomes , Hippocampe , Cellules souches mésenchymateuses , Métamfétamine , Souris de lignée BALB C , Neurogenèse , Animaux , Exosomes/métabolisme , Mâle , Neurogenèse/effets des médicaments et des substances chimiques , Neurogenèse/physiologie , Souris , Métamfétamine/toxicité , Troubles liés aux amphétamines/thérapie , Troubles liés aux amphétamines/psychologie , Troubles liés aux amphétamines/métabolisme , Hippocampe/métabolisme , Hippocampe/effets des médicaments et des substances chimiques , Cognition/effets des médicaments et des substances chimiques , Cognition/physiologie , Apprentissage du labyrinthe/effets des médicaments et des substances chimiques , Apprentissage du labyrinthe/physiologie , /effets des médicaments et des substances chimiques , /physiologie , Protéines de tissu nerveux/métabolisme , Stimulants du système nerveux central/toxicité , Mémoire spatiale/effets des médicaments et des substances chimiques , Mémoire spatiale/physiologie , Protéines des microfilaments/métabolisme , Transplantation de cellules souches mésenchymateuses/méthodes , Protéines de liaison au calcium , Protéines de liaison à l'ADNRÉSUMÉ
BACKGROUND: PRG is derived from Phellinus ribis and is a homogeneous polysaccharide with well-defined structural information. PRG was found to have significant in vitro neurotrophic and neuroprotective activities. Thus, PRG might be a potential treatment for Alzheimer's disease. However, the related mechanisms of action are still unclear, so deeper in vivo experimental validation and the potential mechanisms need to be investigated. PURPOSE: The effects of PRG on AD mice were investigated using Senescence-accelerated SAMP8 mice as an AD model to elucidate the crucial molecular mechanisms. METHODS: PRG was obtained from Phellinus ribis by water-alcohol precipitation, column chromatography, and ultrafiltration. The Morris water maze and novel object recognition behavioral assays were used to evaluate the effects of PRG in AD mice. Nissl staining, the TUNEL apoptosis assay, and Golgi staining were used to assess brain neuronal cell damage, apoptosis, and neuronal status. Enzyme-linked immunosorbent assays, Western blotting, and immunofluorescence were used to explore the impacts of correlated factors and protein pathways under relevant mechanisms. RESULTS: The findings suggest that PRG improved learning ability and spatial memory capacity in SAMP8 mice. PRG hastened the disintegration of ß-amyloid, reduced the content and abnormal accumulation of the toxic Aß1-42 protein, and decreased apoptosis. PRG activated the BDNF/ERK/CREB signaling pathway through a cascade, exerted neurotrophic effects, regulated cell proliferation and differentiation, increased neuronal dendritic branching and spine density, and improved synaptic plasticity. CONCLUSION: PRG promoted ß-amyloid degradation to reduce neuronal damage and apoptosis. It exerted neurotrophic effects by activating the BDNF/ERK/CREB pathway, promoting neuronal dendritic branching and dendritic spine growth, regulating cell proliferation and differentiation, and improving synaptic plasticity, which improved AD. Taken together, as a novel natural active polysaccharide with a well-defined structure, PRG affected AD symptoms in senescence-accelerated mice by interacting with multiple targets. The results indicate that PRG is a promising potential anti-AD drug candidate.